Researchers Determine MBI to be a Useful Adjunct to Mammography

May 7, 2013

Molecular breast imaging (MBI), also known as breast-specific gamma imaging (BSGI), is a relatively new form of breast cancer detection conducted by injecting the patient in the arm with a specialized tracer and then obtaining images of the tracer distribution using detectors. The imaging procedure is similar to that of mammography, but with significantly less compression and each image takes between 5 to 10 minutes to obtain. Previous work has established that it can detect cancers missed by mammography, particularly in patients with dense breast tissue however new research, published earlier this year in the European Journal of Nuclear Medicine and Molecular Imaging, is the largest analysis conducted to date.